U.S. Osteoporosis Market

Publication Date	June 2008
Publisher	Frost & Sullivan
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	FRS00338

Buy this product or for assistance call +44 20 7060 7474

PDF £3,605.00$5997 | €4035

FAX Order above formats by FAX

Summary

This research service covers the U.S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bisphosphonates, selective estrogen receptor modulators, calcitonins, parathyroid hormones, and novel therapeutic approaches. Major market challenges, drivers, and restraints and identified and discussed.

Content

Executive summary
- Executive summary
  - Introduction
Market introduction
- Research scope and methodology
  - Scope & segmentation
  - Research methodology
- Market overview
  - Market engineering measurements
  - Disease overview
  - Treatment options
  - Patient forecasts
  - Industry challenges
  - Market drivers
  - Market restraints
- Product analysis
  - Bisphosphonates
  - Selective estrogen receptor modulators
  - Calcitonins
  - Parathyroid hormones
- Pipeline analysis
  - Bisphosphonates
  - Selective estrogen receptor modulators
  - Calcitonins
  - Parathyroid hormones
  - Novel therapeutic approaches
Competitive analysis
- Competitive analysis
  - Competitive structure
- Forecasts and trends
  - Total market
  - Bisphosphonates
  - Selective estrogen receptor modulators
  - Calcitonins
  - Parathyroid hormones
  - Novel therapeutic approaches
- Market share analysis
  - Company market share
  - Product market share
Appendix
- Decision support databases
  - Male population 65 plus
  - Female population 65 plus
  - Percentage of population 65 plus
  - Total population 65 plus
  - U.s. population with osteoporosis